摘要：We sincerely appreciate Moran and colleagues’ contributions to the discussion about implementing misoprostol for postabortion care (PAC). Many organizations are now working on this issue and sharing information and best practices, as Moran et al. did in their letter, is beneficial to the whole field. They underscore key issues, especially around stakeholder support and sustainable availability of misoprostol. Their data from Zimbabwe about providers’ perception of women’s preferences are significant, both because those providers also see the need for women to have options for care, and because it is another example like ours of providers being the voices for women. Currently, data related to women’s perspectives regarding misoprostol for PAC (MPAC) are limited to acceptability of this service. While acceptability of MPAC is clearly necessary, understanding women’s preferences for PAC treatment modalities is an important area for future research, so services can best meet women’s needs. Moran et al. additionally highlight the importance of ensuring that information presented to patients regarding MPAC is not only scientifically accurate but also culturally appropriate.(Published: 18 July 2013)Citation: Glob Health Action 2013, 6: 21787 - http://dx.doi.org/10.3402/gha.v6i0.21787..............................Read the Letter at: Glob Health Action 2013, 6: 21786 - http://dx.doi.org/10.3402/gha.v6i0.21786
